Literature DB >> 24559584

Cyclooxygenase-2 and vascular endothelial growth factor expressions are involved in ultrafiltration failure.

Jia Guo1, Jing Xiao1, Huanhuan Gao1, Yunfeng Jin1, Zhihong Zhao1, Wenju Jiao1, Zhangsuo Liu1, Zhanzheng Zhao2.   

Abstract

BACKGROUND: Long-term peritoneal dialysis (PD) is associated with ultrafiltration failure (UFF). The aim of the study was to investigate changes in cyclooxygenase-2 (COX-2), vascular endothelial growth factor A (VEGF-A), and vascular endothelial growth factor C (VEGF-C) expressions in a rat model of UFF induced by PD solution.
METHODS: Sprague-Dawley rats were divided into six groups (n = 8/group): normal untreated control group, sham operation group, uremic group (nephrectomy without PD), uremic 2-wk PD group (PD solution for 2 wk), uremic 4-wk PD group (PD solution for 4 wk), and uremic 4-wk PD + celecoxib group (PD solution plus COX-2 inhibitor celecoxib 20 mg/kg for 4 wk). Peritoneal function was determined by peritoneal equilibration test. Peritoneal morphology was determined by hematoxylin and eosin and Masson staining. Microvessel and lymphatic microvessel formation was determined by immunohistochemistry. COX-2, VEGF-A, and VEGF-C expressions were determined by real-time polymerase chain reaction and immunohistochemistry.
RESULTS: Uremic rat model was successfully established. PD-induced peritoneal morphologic changes associated with UFF, characterized by inflammation, edema, and collagen accumulation. PD solution increased the density of microvessels marked by CD31 (microvessel density) and lymphatic microvessels marked by LYVE-1 (lymphatic vessel density) in peritoneum. COX-2, VEGF-A, and VEGF-C expression levels in the uremic 4-wk PD group were higher than those in the uremic group (all P < 0.05). All these changes were partially reversed by celecoxib. VEGF-A and VEGF-C protein expressions were positively correlated with microvessel density and lymphatic vessel density formation.
CONCLUSIONS: COX-2 could increase VEGF-A and VEGF-C expressions in peritoneal tissue, resulting in increased formation of peritoneal microvessels and lymphatic microvessels, playing pivotal roles in the development of UFF.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  COX-2; Celecoxib; Peritoneal dialysis; Ultrafiltration failure; VEGF

Mesh:

Substances:

Year:  2014        PMID: 24559584     DOI: 10.1016/j.jss.2014.01.028

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  4 in total

1.  Sensitive and non-invasive method for the in vivo analysis of membrane permeability in small animals.

Authors:  Andrea Fernandez-Carrera; Eva Vigo; Carla Regueiro-Rodríguez; África González-Fernández; David Olivieri; Luiz S Aroeira
Journal:  Lab Invest       Date:  2017-07-24       Impact factor: 5.662

2.  New Insights into the Effects of Chronic Kidney Failure and Dialysate Exposure on the Peritoneum.

Authors:  Carmen A Vlahu; Jan Aten; Marijke de Graaff; Henk van Veen; Vincent Everts; Dirk R de Waart; Dirk G Struijk; Raymond T Krediet
Journal:  Perit Dial Int       Date:  2016-05-04       Impact factor: 1.756

3.  Microarray analysis reveals long non‑coding RNA SOX2OT as a novel candidate regulator in diabetic nephropathy.

Authors:  Xiaoxue Zhang; Jin Shang; Xiaoyang Wang; Genyang Cheng; Yumin Jiang; Dong Liu; Jing Xiao; Zhanzheng Zhao
Journal:  Mol Med Rep       Date:  2018-10-04       Impact factor: 2.952

Review 4.  Experimental models in peritoneal dialysis (Review).

Authors:  Bo Yang; Mengmeng Wang; Xue Tong; Ghada Ankawi; Lin Sun; Hongtao Yang
Journal:  Exp Ther Med       Date:  2021-01-21       Impact factor: 2.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.